File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Cannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization

TitleCannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization
Authors
Issue Date2024
Citation
Journal of Affective Disorders, 2024, v. 351, p. 853-862 How to Cite?
AbstractAims: Cannabis use may increase the risk of self-harm, but whether legalization of cannabis is associated with changes in self-harm is unknown. We examined changes in cannabis-involvement in emergency department (ED) visits for self-harm after the liberalization of medical and legalization of non-medical cannabis in Canada. Methods: This repeated cross-sectional study used health administrative data to identify all ED visits for self-harm in individuals aged ten and older between January 2010 and December 2021. We identified self-harm ED visits with a co-diagnosis of cannabis (main exposure) or alcohol (control condition) and examined changes in rates of visits over four distinct policy periods (pre-legalization, medical liberalization, non-medical legalization with restrictions, and non-medical commercialization/COVID-19) using Poisson models. Results: The study included 158,912 individuals with one or more self-harm ED visits, of which 7810 (4.9 %) individuals had a co-diagnosis of cannabis use and 24,761 (15.6 %) had a co-diagnosis of alcohol use. Between 2010 and 2021, the annual rate of ED visits for self-harm injuries involving cannabis per 100,000 individuals increased by 90.1 % (3.6 in 2010 to 6.9 in 2021 per 100,000 individuals), while the annual rate of self-harm injuries involving alcohol decreased by 17.3 % (168.1 in 2010 to 153.1 in 2021 per 100,000 individuals). The entire increase in visits relative to pre-legalization occurred after medical liberalization (seasonally adjusted Risk Ratio [asRR] 1.71 95 % CI 1.09–1.15) with no further increases during the legalization with restrictions (asRR 1.77 95%CI 1.62–1.93) or commercialization/COVID-19 periods (asRR 1.63 95%CI 1.50–176). Conclusions: Cannabis-involvement in self-harm ED visits almost doubled over 12 years and may have accelerated after medical cannabis liberalization. While the results cannot determine whether cannabis is increasingly causing self-harm ED visits or whether cannabis is increasingly being used by individuals at high risk of self-harm, greater detection for cannabis use in this population and intervention may be indicated.
Persistent Identifierhttp://hdl.handle.net/10722/347093
ISSN
2023 Impact Factor: 4.9
2023 SCImago Journal Rankings: 2.082

 

DC FieldValueLanguage
dc.contributor.authorMyran, Daniel T.-
dc.contributor.authorGaudreault, Adrienne-
dc.contributor.authorPugliese, Michael-
dc.contributor.authorTanuseputro, Peter-
dc.contributor.authorSaunders, Natasha-
dc.date.accessioned2024-09-17T04:15:20Z-
dc.date.available2024-09-17T04:15:20Z-
dc.date.issued2024-
dc.identifier.citationJournal of Affective Disorders, 2024, v. 351, p. 853-862-
dc.identifier.issn0165-0327-
dc.identifier.urihttp://hdl.handle.net/10722/347093-
dc.description.abstractAims: Cannabis use may increase the risk of self-harm, but whether legalization of cannabis is associated with changes in self-harm is unknown. We examined changes in cannabis-involvement in emergency department (ED) visits for self-harm after the liberalization of medical and legalization of non-medical cannabis in Canada. Methods: This repeated cross-sectional study used health administrative data to identify all ED visits for self-harm in individuals aged ten and older between January 2010 and December 2021. We identified self-harm ED visits with a co-diagnosis of cannabis (main exposure) or alcohol (control condition) and examined changes in rates of visits over four distinct policy periods (pre-legalization, medical liberalization, non-medical legalization with restrictions, and non-medical commercialization/COVID-19) using Poisson models. Results: The study included 158,912 individuals with one or more self-harm ED visits, of which 7810 (4.9 %) individuals had a co-diagnosis of cannabis use and 24,761 (15.6 %) had a co-diagnosis of alcohol use. Between 2010 and 2021, the annual rate of ED visits for self-harm injuries involving cannabis per 100,000 individuals increased by 90.1 % (3.6 in 2010 to 6.9 in 2021 per 100,000 individuals), while the annual rate of self-harm injuries involving alcohol decreased by 17.3 % (168.1 in 2010 to 153.1 in 2021 per 100,000 individuals). The entire increase in visits relative to pre-legalization occurred after medical liberalization (seasonally adjusted Risk Ratio [asRR] 1.71 95 % CI 1.09–1.15) with no further increases during the legalization with restrictions (asRR 1.77 95%CI 1.62–1.93) or commercialization/COVID-19 periods (asRR 1.63 95%CI 1.50–176). Conclusions: Cannabis-involvement in self-harm ED visits almost doubled over 12 years and may have accelerated after medical cannabis liberalization. While the results cannot determine whether cannabis is increasingly causing self-harm ED visits or whether cannabis is increasingly being used by individuals at high risk of self-harm, greater detection for cannabis use in this population and intervention may be indicated.-
dc.languageeng-
dc.relation.ispartofJournal of Affective Disorders-
dc.titleCannabis-involvement in emergency department visits for self-harm following medical and non-medical cannabis legalization-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.jad.2024.01.264-
dc.identifier.pmid38309479-
dc.identifier.scopuseid_2-s2.0-85184816433-
dc.identifier.volume351-
dc.identifier.spage853-
dc.identifier.epage862-
dc.identifier.eissn1573-2517-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats